DexCom Increases IPO Pricing

Venture-backed glucose monitoring systems maker DexCom has bumped up the value of its initial public offering (IPO) by 8 percent to $75.7 million. The San Diego, Calif.-based company set the terms of the 4.7 million share offering at $12 to $14 an issue. On Feb. 1, DexCom estimated the IPO's value at $70 million.

TheDeal.com (http://www.thedeal.com/NASApp/cs/ContentServer?pagename=TheDeal/TDDArticle/StandardArticle&c=TDDArticle&cid=1111624424786&r=InFs&p=M4YD5AR2)